X T L Biopharmaceuticals reported $-43K in Gross Profit on Sales for its fiscal quarter ending in December of 2024.





Gross Profit On Sales Change Date
Alaunos Therapeutics USD -1.13M 1.11M Sep/2024
Bioline Rx USD 343K 111K Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025
X T L Biopharmaceuticals USD -43K 89K Dec/2024